Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.98
+0.06 (1.01%)
At close: Dec 5, 2025, 4:00 PM EST
5.96
-0.02 (-0.33%)
After-hours: Dec 5, 2025, 7:36 PM EST
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.45 billion as of December 5, 2025. Its market cap has increased by 23.68% in one year.
Market Cap
1.45B
Enterprise Value
1.45B
1-Year Change
23.68%
Ranking
Category
Stock Price
$5.98
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.45B, an increase of 498.68%. That is a compound annual growth rate of 16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.44B | 19.78% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |